17.7 C
New York
Wednesday, June 17, 2026

Tag: PDF

newssourceFORcompanyinformationcontent1marketreleases

Polybutylene Adipate Terephthalate Market worth $2.76 billion by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Aug 8, 2025 /PRNewswire/ -- The report "Polybutylene Adipate Terephthalate Market by Grade, Application (Films, Sheets & Bin Liners, Coatings & Adhesives, Molded Products, Fibers),...

Denison Reports Financial and Operational Results for Q2 2025, Highlighted by Return to Uranium Production at McClean Lake and Provincial Approval of Wheeler River...

TORONTO, Aug. 7, 2025 /CNW/ - Denison Mines Corp. ('Denison' or the 'Company') (TSX: DML) (NYSE American: DNN) today filed its Condensed Consolidated Financial Statements and...

Denison Reports Financial and Operational Results for Q2 2025, Highlighted by Return to Uranium Production at McClean Lake and Provincial Approval of Wheeler River...

TORONTO, Aug. 7, 2025 /PRNewswire/ - Denison Mines Corp. ('Denison' or the 'Company') (TSX: DML) (NYSE American: DNN) today filed its Condensed Consolidated Financial Statements and...

LUNDIN GOLD REPORTS SECOND QUARTER 2025 RESULTS

Exceptional operating performance drives record revenues and free cash flow VANCOUVER, BC, Aug. 7, 2025 /CNW/ - Lundin Gold Inc.  (TSX: LUG) (Nasdaq Stockholm: LUG)...

LUNDIN GOLD DECLARES QUARTERLY DIVIDENDS OF US$0.79 PER SHARE

VANCOUVER, BC, Aug. 7, 2025 /CNW/ - Lundin Gold Inc. (TSX: LUG) (Nasdaq Stockholm: LUG) (OTCQX: LUGDF) ("Lundin Gold" or the "Company") is pleased...

Peracetic Acid Market worth $1.67 billion in 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Aug. 7, 2025 /PRNewswire/ -- The report "Peracetic Acid Market by Grade (<5% Grade, 5–15% Grade, >15% Grade), Application (Disinfectant, Sterilant,...

Peracetic Acid Market worth $1.67 billion in 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Aug. 7, 2025 /PRNewswire/ -- The report "Peracetic Acid Market by Grade (<5% Grade, 5–15% Grade, >15% Grade), Application (Disinfectant, Sterilant,...

MiTAC Computing Partners with Industry Leaders on Open AI Server Solutions at OCP APAC Summit 2025

TAIPEI, Aug. 7, 2025 /PRNewswire/ -- MiTAC Computing Technology Corporation, a leading server platform designer, manufacturer, and a subsidiary of MiTAC Holdings Corporation (TSE:3706),...

MiTAC Computing Partners with Industry Leaders on Open AI Server Solutions at OCP APAC Summit 2025

TAIPEI, Aug. 7, 2025 /PRNewswire/ -- MiTAC Computing Technology Corporation, a leading server platform designer, manufacturer, and a subsidiary of MiTAC Holdings Corporation (TSE:3706),...

MiTAC Computing Partners with Industry Leaders on Open AI Server Solutions at OCP APAC Summit 2025

TAIPEI, Aug. 6, 2025 /CNW/ -- MiTAC Computing Technology Corporation, a leading server platform designer, manufacturer, and a subsidiary of MiTAC Holdings Corporation (TSE:3706),...

Implantica announces second publication of groundbreaking 5-year results from the landmark RefluxStop® clinical study

VADUZ, Liechtenstein, Aug. 7, 2025 /PRNewswire/ -- Implantica AG (publ), a leading medtech company pioneering advanced implantable medical technologies, today announced the second peer-reviewed...

MEREN TO RELEASE SECOND QUARTER 2025 FINANCIAL RESULTS ON TUESDAY, AUGUST 12, 2025

VANCOUVER, BC, Aug. 7, 2025 /CNW/ - (TSX: MER) (Nasdaq-Stockholm: MER) – Meren Energy Inc. ("Meren" or the "Company") will publish its financial and operating results, along with the...

Harvia’s Half-year financial review 1 January – 30 June 2025

Harvia Plc, Half-year financial review 7 August 2025 at 9:00 a.m. EEST

Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information

Saint Herblain (France), August 7, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the FDA has removed its recommended pause in the use of IXCHIQ® in individuals 60 years of age and older and has approved updates to the Prescribing Information (PI) for IXCHIQ®. IXCHIQ® remains indicated in the United States for the prevention of disease caused by the Chikungunya Virus (CHIKV) in individuals 18 years of age and older who are at high risk of exposure to CHIKV.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPDF

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers